Last reviewed · How we verify

NCT04811066

Motor Learning and Multi-session tDCS in Parkinson's Disease

Completed NA Last updated 13 June 2022
What this trial tests

NA trial testing Transcranial direct current stimulation in Parkinson Disease in 48 participants. Completed in 2 October 2021.

Timeline
19 April 2021
Primary endpoint
2 October 2021
2 October 2021

Quick facts

Lead sponsorThe Hong Kong Polytechnic University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment48
Start date19 April 2021
Primary completion2 October 2021
Estimated completion2 October 2021
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 40 to 80, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study seeks to examine the efficacy of multi-session transcranial direct current stimulation applied over the primary motor cortex in people with Parkinson's disease on sequential motor learning performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Transcranial direct current stimulation

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04811066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing